These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30388628)

  • 1. Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris.
    Wang SC; Liao HY; Zhang JY; Cheng TR; Wong CH
    Virology; 2019 Jan; 526():125-137. PubMed ID: 30388628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice.
    van der Lubbe JEM; Verspuij JWA; Huizingh J; Schmit-Tillemans SPR; Tolboom JTBM; Dekking LEHA; Kwaks T; Brandenburg B; Meijberg W; Zahn RC; Roozendaal R; Kuipers H
    Front Immunol; 2018; 9():2350. PubMed ID: 30369928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
    Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.
    Impagliazzo A; Milder F; Kuipers H; Wagner MV; Zhu X; Hoffman RM; van Meersbergen R; Huizingh J; Wanningen P; Verspuij J; de Man M; Ding Z; Apetri A; Kükrer B; Sneekes-Vriese E; Tomkiewicz D; Laursen NS; Lee PS; Zakrzewska A; Dekking L; Tolboom J; Tettero L; van Meerten S; Yu W; Koudstaal W; Goudsmit J; Ward AB; Meijberg W; Wilson IA; Radošević K
    Science; 2015 Sep; 349(6254):1301-6. PubMed ID: 26303961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
    Liao HY; Wang SC; Ko YA; Lin KI; Ma C; Cheng TR; Wong CH
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17757-17763. PubMed ID: 32669430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes.
    Smatti MK; Nasrallah GK; Al Thani AA; Yassine HM
    Vaccine; 2020 Jan; 38(4):815-821. PubMed ID: 31735504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.
    Wei CJ; Boyington JC; McTamney PM; Kong WP; Pearce MB; Xu L; Andersen H; Rao S; Tumpey TM; Yang ZY; Nabel GJ
    Science; 2010 Aug; 329(5995):1060-4. PubMed ID: 20647428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus.
    Hung JT; Tsai YC; Lin WD; Jan JT; Lin KH; Huang JR; Cheng JY; Chen MW; Wong CH; Yu AL
    Antiviral Res; 2014 Jul; 107():110-8. PubMed ID: 24786174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yeast expressed recombinant Hemagglutinin protein of novel H1N1 elicits neutralising antibodies in rabbits and mice.
    Athmaram TN; Saraswat S; Santhosh SR; Singh AK; Suryanarayana WS; Priya R; Gopalan N; Parida M; Rao PV; Vijayaraghavan R
    Virol J; 2011 Nov; 8():524. PubMed ID: 22126628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
    Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
    Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant haemagglutinin protein of highly pathogenic avian influenza A (H5N1) virus expressed in Pichia pastoris elicits a neutralizing antibody response in mice.
    Murugan S; Ponsekaran S; Kannivel L; Mangamoori LN; Chandran D; Villuppanoor Alwar S; Chakravarty C; Lal SK
    J Virol Methods; 2013 Jan; 187(1):20-5. PubMed ID: 22871671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of avian influenza virus (H5N1) hemagglutinin and matrix protein 1 in Pichia pastoris and evaluation of their immunogenicity in mice.
    Subathra M; Santhakumar P; Satyam Naidu S; Lakshmi Narasu M; Senthilkumar TM; Lal SK
    Appl Biochem Biotechnol; 2014 Apr; 172(7):3635-45. PubMed ID: 24562978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.
    Whittle JR; Wheatley AK; Wu L; Lingwood D; Kanekiyo M; Ma SS; Narpala SR; Yassine HM; Frank GM; Yewdell JW; Ledgerwood JE; Wei CJ; McDermott AB; Graham BS; Koup RA; Nabel GJ
    J Virol; 2014 Apr; 88(8):4047-57. PubMed ID: 24501410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.
    Sun W; Kirkpatrick E; Ermler M; Nachbagauer R; Broecker F; Krammer F; Palese P
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prime/boost vaccination with HA DNA and Pichia-produced HA protein elicits a strong humoral response in chickens against H5N1.
    Stachyra A; Pietrzak M; Macioła A; Protasiuk A; Olszewska M; Śmietanka K; Minta Z; Góra-Sochacka A; Kopera E; Sirko A
    Virus Res; 2017 Mar; 232():41-47. PubMed ID: 28159612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.